Advances in poison management
MARC J. BAYER13 Activated charcoal now has an undisputed role in the management of poisoned patients.Recently, the use of ipecac-induced emesis, orogastric lavage, cathartics, activated charcoal, whole-bowel irrigation, and combinations of these treatments has been subjectedto limitedscientific studies. The results of these analysesare detailed. Antidotal treatment isusefulin certain situations. Naloxone rapidly reversesopiate overdoses,while oxygen is a specific antidote for GO poisoning.
Newer antidotes have been developed to reverse toxicity from digitalis (Fab fragment antibodies) and from benzodiazepines (flumazenil). The appropriate indications for the use of these and other antidotes as well as the toxicity associated with theiruse are reviewed.
Advances in Gasbic Decontamination
Interference with absorption of ingested poison from the gastrointestinal tract is the mainstay of poison management.
Because few specific antidotes are available to treat poisonings, absorption prevention, observation, and supportive care are the clinician's greatestassets."Pumping the stomach" has been advocated forthe removal of poisons sincethe beginning of the 19th century.Syrup of ipecachas been used asan emetic for the management of poisoned patients since the 1950s. During the lastdecade, however, the efficacyand inherent risksof these methods of gastric decontamination have been questioned.
Other methods-e.g., activatedcharcoal in singleor multiple doses, cathartics, and whole-bowel irrigation-have been examined as to effectiveness and limitations. This article reviews the various techniques used in gastric decontamination and outlines theirrisksand benefits.
EFFICACY

OF GASTRIC EMPTYING
Several studies [1] [2] [3] have demonstrated thatgastric lavageisno more effective than ipecacemesis induced in specific instances.
Other investigators, however, [4, 5] have challengedthose studieson the basisof improper technique.Comparative efficacy is alsodifficult to evaluatebecause studieshave oftenbeen carried out with animals and in nonoverdose situations. However, existing data infer that gastric lavage performed by traditional methods isabout as effective as emesis in recovering stomach contents. Use of either gastric-emptying mechanism generally returns -30% of the stomach contents at 1 h postingestion [6] [7] [8] . The effectiveness of both gastriclavage and ipecac in removing stomach contents is time dependent. Unfortunately, many overdose patients do not arrive to the emergency department within 1 h of theiringestions. Although emptying the stomach in the first hour generally works and may be beneficial for severalhours, it isusuallynot helpfulbeyond 4 h postingestion.
Ipecac is contraindicated in ingestions of caustic substances and volatile hydrocarbons, in patientswho have decreased gag reflexor alteredmental status, and in patientsat riskfor rapid alterationin consciousness.Complications of ipecac include aspiration pneumonia, lethargy, diaphragmatic rupture, Mallory-Weiss esophageal tears, and intracerebral hemorrhage [9] . Currently, ipecac syrup is rarely used in emergency departments because it may induce prolonged episodes of vomiting, thereby delaying initiation of activated charcoal treatment. Its use is generally limited to the pediatric population, in whom accidental poisonings are usually discovered quickly. Ipecac is also still recommended by poison control centers for use in the home, where earlyadministrationcan be assured. Gastric lavagecarriespotentialcomplications,includingaspiration pneumonitis and, rarely, esophageal perforation. Gas-tric lavagecan also promote the rapid passage of tablets into the small bowel ratherthan removing them. The efficacyof both ipecac and gastriclavage has been questioned,particularly in light of recent clinical outcome studies. Kulig et al. [10] , in a prospective study of >592 patients,addressed the issue of whether gastric emptying with eithersyrup of ipecac or gastric lavage followed by activatedcharcoalwas more effective than activatedcharcoal alone in overdose emergency department patients. They determined that syrup of ipecac did not alter the outcome of patientswho arrivedin the emergency department awake and alert. Gastric lavage improved clinical outcome in obtunded patientsonly ifperformed within 1 h of ingestion. Severalsubequent studies [11, 12] The patientshould be placed in a leftlateral decubitus positionto decreasedrug absorption and reduce the riskof aspiration.
ACTIVATED CHARCOAL
Activatedcharcoalhas been used in the treatmentof poisonings since 1830, when its effects were firstdemonstrated by the French chemist Bertrand [13] . Produced by pyrolysis of carboncontainingmaterialsand activated by oxidationwith steam at a high temperature,theseprocessedcarbon products adsorb most drugs; only very small highly charged molecules or ions resist adsorption to this material [14] .The surface area of most commercially available activated charcoals is -1000 m2/g. In addition to direct intraluminal binding, activated charcoal can alsodecrease the resorptionof agents that undergo enterohepatic or enterogastric cycling. Convincing evidence also supports the existence of a "gastrointestinal dialysis" effect, whereby the charcoal servesas a large"sink" with movement of toxin molecules across semipermeable membranes from the splanchnic circulation [15] . Traditionally, activated charcoal was used as an adjunctto lavageand ipecac-inducedemesis.During the last decade, however, activated charcoal became increasingly popular as a first-line agent for the treatment of poisonings, particularly if more than several hours had passed since ingestion. Activated charcoal is generallyconsidered ineffective against caustics, ethanol, ethylene glycol, methanol, iron, lithium, metals, and petroleum distillates.
Complications from activated charcoal are rare but have included aspirationof activated charcoaland gastriccontents as well as intestinal obstruction, particularly when repeated doses of activated charcoal are given [16] [17] [18] . [20, 21] .
WHOLE-BOWEL IRRIGATION
Recently, polyethylene glycol-electrolyte solutions, which once were used for bowel cleansing before surgical procedures, have been appliedforgastrointestinal decontamination.These isoosmotically balanced, nonabsorbable solutions are safe, causing no fluidretentionor electrolyte disturbances. Theoretically, wholebowel irrigation may be useful for managing patients who have taken toxins that are not adsorbed by activatedcharcoal or sustained-release preparations that continue to be absorbed in the small intestine. The procedure has been advocated for overdoses of agents such as iron,lithium,and enteric-coated or sustained-release medications [22] [23] [24] .
In practice, hemodynamically stable and cooperative patients are best suited to this intensive cathartic treatment.
For the procedure to be effective, adultsshould ingestthe solutionat a rateof 2 L/h, children at 500 mL/h. The solutioncan alsobe given through a nasogastric tube. The endpoint of treatment isa cleareffluent, which may take 4-6 h to appear. A combination of activated charcoal (without cathartic) and whole-bowel irrigation can be effective in some situations(e.g., for a cocaine body packer),but the polyethylene glycol-electrolyte solution reduces the binding efficacyof charcoal,requiring an increasein the amount of activated charcoalused [25, 26] . One of the risks of polyethylene glycol delivery is vomiting, but this appears to be related to how fastthe fluidisgiven.Contraindicationsto whole-bowel irrigation includeileusor bowel obstruction. They interpret the report of a negative screen as meaning "no drugs present."
Laborato.y Tests
Education of clinicians regarding the limitsof these technologies (e.g., problems in sample extraction, or cross-reactivity of variousimmunoassays, or the relatively time-intensive nature of matching positive chromatographic "hits") isneeded. Two-way communication between the laboratoryand the clinician, with consideration of the history available and any toxic syndromes present, will determine the best testing strategy for the individual patient and increase the value of the information received.
Rational Use of Antidotes
Antidotes are commonly thought of as chemical or physiological
antagoniststhat prevent the toxicological effectof specific poisons.This differentiates them from agentsused to ameliorate the sequelae of the toxicological effectsof poisons. In most toxicological emergencies, effective antidotes are not available. Symptomatic treatment and supportive care are still the primary approach to treatment; antidotal therapy often plays a relatively minor role. When appropriately used in specific situations, however, antidotes can substantially reduce morbidity and mortality in the poisoned patient.
Oxygen vs carbon monoxide.Oxygen is a specific antidote for CO poisoning.
The effects of CO in concentrations encountered clinically are based on its combination with hemoglobin, displacement of oxygen, and consequent disruption of the oxygen transport system. CO competes with oxygen for a binding site in the hemoglobin molecule. The resulting carboxyhemoglobin formed has no practical function as a carrier of oxygen. Because CO affinity for hemoglobin is 230-270 times as great as that of oxygen, the latter israpidlydisplaced, and the oxygen-carrying capacity of blood is concomitantly reduced. Thus, very small concentrations of CO cause high concentrations of carboxyhemoglobin.
The primary and definitive treatment for GO poisoning is the administrationof oxygen: Within the limitsof toxicity, the more oxygen given, the more effective the treatment. The immediate therapeutic goal is to reverse cerebral and myocardial hypoxia; the second concern is to accelerateCO elimination. Both goals are achieved simultaneously by adequate oxygen administration. Oxygen is transportedin blood, both bound to hemoglobin and dissolved in plasma. Although GO inactivates hemoglobin, it is without effect on dissolved oxygen. In air breathing, the concentration of dissolved oxygen is low but increases with increasing inspired oxygen tensions. One hundred percent oxygen in atmospheric pressure can result in dissolvedoxygen content as high as 20.9 mL/L. Given thatthe whole-body arterial to venous oxygen content difference is usually 50-60 mLJL, administration of 100% oxygen can supply one-third of the oxygen demand in dissolved form [27] . Administration of 100% oxygen should be by use of a nonbreathing mask or endotrachealintubation. This can effectively reduce the half-life of carboxyhemoglobin dissociation from 300 mm to between 60 and 90 mm. and Delta-2 receptors are found in the brain; the Mu-2, Kappa-l, and Delta-l receptors arein the spinalcord [28] . Analgesia occurs from stimulating the Mu receptors at a supraspinal level and the Kappa receptors at a spinallevel.
In the last 10-20 years, so-called designer drugs have emerged from illicit manufacturers. These drugs include the fentanyl derivatives, which can be 100-3000 times more potent than morphine, and analogs of meperidine. Naloxone is effective in reversing the effects of these opioids and should be given in an initial dose of 2 mg. If reversal is successful, the effective dose may need to be repeated every 20-30 mm for several hours to avoid renarcotization, because the half-life of naloxone is much shorter than that of most opioids. Alternatively, continuous infusion of two-thirds of the originally effective dose per hour can be started. The only adverse effect of naloxone in the overdose patientisthe riskof precipitating withdrawal symptoms in a narcotic addict. Naloxone can be given through subcutaneous, intramuscular, endotracheal, and sublingual routes. The intravenous route is preferred because its onset of action is more rapid and reliable. Naloxone works as a competitive antagonist to Mu, Kappa, and Delta opioid receptor sites, antagonizing the sedative, analgesic, and miotic effects by displacing the opiate and binding rapidly to its receptors.
Higher doses of naloxone are often needed to reverse the effects of synthetic narcotics.
Fab fragment antibodies vs digitalis. Specific Fab fragment antibodies, first used to reverse human poisoning in 1976, were proved to be safe and effective by Antman et al. [29] in a multicenter trial of 150 patients with life-threatening digitalis intoxication treatedwith Fab fragment antibodies. The patients, who ranged in age from 1 day to 94 years, had both acute and chronicoverdoses.The median ingesteddose of digoxinin acute overdoses was 12.5 mg. The median serum digoxin concentration was 8 ng/mL. Life-threateningcomplications included refractory ventricular tachycardia, ventricular fibrillation, highgrade atrioventricular block, and hyperkalemia.Most patients improved strikingly when treated with digoxin-specific antibodies: In 80% intoxication resolved completely, and in 10% signs and symptoms lessened. 
